Zhejiang AngLiKang Pharmaceutical CO.,LTD. - ROE
002940.SZ
Price:
$21.65
Market Cap:
$4.25B
Zhejiang AngLiKang Pharmaceutical CO.,LTD. is a company primarily focused on the manufacturing and distribution of various pharmaceutical goods. Their operations span the production and sale of active pharmaceutical ingredients (APIs), finished drug formulations, and empty capsules for medical use. The company's existing product line encompasses treatments for a variety of conditions, including anti-infective agents, antihypertensives for blood pressure management, medications for digestive system health, and respiratory preparations. Beyond its current offerings, AngLiKang is also deeply involved in drug research and development. Their R&D efforts are concentrated on creating new therapies,...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-10-23
Stock Exchange
SHZ
Ticker
002940.SZ
PE Ratio
[37.10]
ROE
[7.02%]
Current Ratio
[1.99]
Dividend Yield
[1.15%]
Enterprise Value
[4.51B]
Dividend History
The ROE as of October 2026 (TTM) for Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) is 7.02%
According to Zhejiang AngLiKang Pharmaceutical CO.,LTD.’s latest financial reports and current stock price. The company's current ROE is 7.02%. This represents a change of 301.22% compared to the average of 1.75% of the last 4 quarters.
Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) Historical ROE (quarterly & annually)
How has 002940.SZ ROE performed in the past?
The mean historical ROE of Zhejiang AngLiKang Pharmaceutical CO.,LTD. over the last ten years is 12.87%. The current 7.02% ROE has changed -45.47% with respect to the historical average. Over the past ten years (40 quarters), 002940.SZ's ROE was at its highest in in the June 2018 quarter at 11.97%. The ROE was at its lowest in in the September 2024 quarter at -1.20%.
Average
12.87%
Median
10.29%
Minimum
5.25%
Maximum
27.31%
Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) ROE by Quarter and Year
Discovering the peaks and valleys of Zhejiang AngLiKang Pharmaceutical CO.,LTD. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 46.87%
Maximum Annual ROE = 27.31%
Minimum Annual Increase = -56.69%
Minimum Annual ROE = 5.25%
| Year | ROE | Change |
|---|---|---|
| 2025 | 7.71% | 46.87% |
| 2024 | 5.25% | -39.83% |
| 2023 | 8.72% | 2.98% |
| 2022 | 8.47% | -5.36% |
| 2021 | 8.95% | -27.89% |
| 2020 | 12.41% | 6.71% |
| 2019 | 11.63% | -1.64% |
| 2018 | 11.83% | -56.69% |
| 2017 | 27.31% | 3.28% |
| 2016 | 26.44% | 2.19% |
Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) Average ROE
How has 002940.SZ ROE performed in the past?
The current ROE of Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.23%
5-year avg
7.82%
10-year avg
12.87%
Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) ROE vs. Peers
How is 002940.SZ’s ROE compared to its peers?
Zhejiang AngLiKang Pharmaceutical CO.,LTD.’s ROE is greater than Beijing SL Pharmaceutical Co., Ltd. (-13.85%), less than Jiuzhitang Co., Ltd. (8.82%), less than Northeast Pharmaceutical Group Co., Ltd. (3.91%), less than Shandong Wit Dyne Health Co.,Ltd. (14.90%), less than China Animal Husbandry Industry Co., Ltd. (2.45%), less than Guizhou Xinbang Pharmaceutical Co., Ltd. (1.66%), greater than Hainan Haiyao Co., Ltd. (-831.41%), less than PharmaBlock Sciences (Nanjing), Inc. (3.58%), less than Harbin Gloria Pharmaceuticals Co., Ltd (17.25%), less than Jiangsu Kanion Pharmaceutical Co.,Ltd. (6.37%),
| Company | ROE | Market cap |
|---|---|---|
| -13.85% | $5.43B | |
| 8.82% | $7.40B | |
| 3.91% | $6.81B | |
| 14.90% | $5.72B | |
| 2.45% | $6.80B | |
| 1.66% | $5.54B | |
| -831.41% | $5.47B | |
| 3.58% | $10.26B | |
| 17.25% | $7.87B | |
| 6.37% | $6.99B |
Build a custom stock screener for Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zhejiang AngLiKang Pharmaceutical CO.,LTD. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Zhejiang AngLiKang Pharmaceutical CO.,LTD. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Zhejiang AngLiKang Pharmaceutical CO.,LTD.'s ROE?
How is the ROE calculated for Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ)?
What is the highest ROE for Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ)?
What is the 3-year average ROE for Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ)?
What is the 5-year average ROE for Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ)?
How does the current ROE for Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) compare to its historical average?